immune system: from textbook PT2.

SECTION FOUR: Protection of the Body and Continuation of the Species

Overview of Immune Cells

  • Natural Killer (NK) Cells

    • Functions:

    • Target abnormal cells like virus-infected or mutated cells.

    • Recognize unusual markers on cell membranes recognized as foreign.

    • Immediate destruction of identified abnormal cells.

    • Effectiveness:

    • Particularly effective against pre-cancerous cells and certain viral infections, including herpes.

    • Comparison:

    • Less selective than T-cells and B-cells regarding target identification.

Immunity

Learning Outcomes
  • Discuss the roles of different types of T-cells in providing cell-mediated immunity.

  • Describe the process of antibody-mediated immunity.

  • Differentiate between artificially and naturally acquired immunity with examples.

  • Distinguish between active and passive immunity with examples.

Lines of Defense
  • First Line of Defense: Non-specific innate defenses like phagocytes (e.g., macrophages).

  • Activation of Immune System:

    • If innate defenses are overwhelmed, the immune system activates.

    • Immune system has three key attributes:

    1. Specificity: Targets only one antigen.

    2. Memory: Creates immunological memory for faster responses in subsequent encounters with the same antigen.

    3. Tolerance: Prevents immune cells from attacking healthy body tissues by recognizing self-markers.

Specific Defenses

Specificity
  • Immune responses are focused on specific antigens unlike general non-specific responses.

  • Key immune cells: T-cells and B-cells

    • Each cell recognizes only one specific receptor pattern.

Memory
  • After the first exposure to an antigen, the immune response builds memory, allowing quicker and stronger reactions on subsequent exposures to the same antigen.

Tolerance
  • Immunological Tolerance: The body’s immune cells ignore healthy self-cells while targeting non-self antigens.

  • Development of tolerance occurs during fetal development by deleting self-reacting lymphocytes.

  • Failure to achieve complete tolerance can lead to autoimmunity (autoimmune diseases).

Lymphocytes

  • Lymphocyte Composition:

    • Comprises 20%-30% of circulating white blood cells.

    • Types include NK cells, T-cells (majority), and B-cells.

  • Production Site:

    • Both T- and B-cells are produced in bone marrow, but T-cells mature in the thymus.

    • They carry antigen recognition molecules to detect and respond to specific antigens.

T-cells

  • Hormone Thymosin: Promotes T-cell maturation, leading to the formation of specialized functional T-cells.

  • Specificity of T-cells:

    • Each T-cell is programmed to react only to one type of antigen.

    • Example: A T-cell for chickenpox will not respond to measles.

  • Function: Provides cell-mediated immunity.

B-cells

  • B-cells originate and mature in bone marrow.

  • Function: Produce antibodies (immunoglobulins) targeting specific antigens.

  • Upon activation, B-cells enlarge and proliferate, producing:

    • Plasma Cells: Secrete antibodies and are the main effector cells of the B-cell response.

    • Memory B-cells: Long-lived cells providing rapid response for future encounters with the same antigen.

  • Activation: Requires helper T-cells to produce antibodies.

Antibody-Mediated Immunity (Humoral Immunity)

  • B-cells recognize antigens directly without needing presentation by antigen-presenting cells (APCs).

  • Each B-cell undergoes clonal expansion after activation.

  • Plasma Cells:

    • Live less than a day, produce millions of antibodies specific to the activating antigen.

    • Antibodies serve roles:

    1. Bind and label antigens for destruction by other immune cells (e.g., macrophages).

    2. Neutralize bacterial toxins.

    3. Activate complement pathway.

Types of Antibodies (Table 15.2)
  • IgA: Found in secretions like breast milk and saliva; prevents antigens from crossing epithelial membranes.

  • IgD: Functions in B-cell activation.

  • IgE: Associated with allergic responses; found on basophils and mast cells.

  • IgG: The most abundant antibody; crosses the placenta, providing fetal protection.

  • IgM: First antibody produced during primary response; strong activator of the complement system.

Immune Response

Primary Immune Response
  • First exposure to an antigen leads to slow production of antibodies (mainly IgM), peaking 2-3 weeks later due to T-cell activation and B-cell proliferation.

Secondary Immune Response
  • Rapid and robust antibody production occurs during subsequent exposure, mainly IgG, which is more effective than IgM.

  • Reinforcements from memory cells enhance the immune response via booster vaccinations.

Types of Acquired Immunity

  • Active Immunity: Immunity that develops after exposure to an antigen, with T-cell and B-cell activation leading to memory cell production.

  • Passive Immunity: Conferred by the introduction of antibodies produced by another organism.

Types of Active Immunity
  • Naturally Acquired: Immunity from natural exposure to infections that creates memory cells.

  • Artificially Acquired: Immunity resulting from vaccination using weakened or killed organisms, or pathogen fragments.

Types of Passive Immunity
  • Naturally Acquired: Antibodies passed from mother to fetus through the placenta or breast milk.

  • Artificially Acquired: Ready-made antibodies injected from recovered individuals or produced using recombinant DNA technology.

Summary of Immune Response Sequence to Infection

  1. Non-specific defense cells accumulate at the infection site (neutrophils, NK cells, macrophages).

  2. If needed, T-cells activate and proliferate to form cytotoxic and helper T-cells, thus activating B-cells.

  3. B-cells differentiate into plasma cells, and antibody production commences, increasing immunity.

Diseases Preventable by Vaccination (Box 15.1)

  • Includes: Anthrax, Cholera, Diphtheria, Hepatitis B, Measles, Mumps, Poliomyelitis, Rubella, Smallpox, Tetanus, Tuberculosis, Typhoid, Whooping cough.